Vivos Therapeutics, Inc.
VVOS
Last
$0.15
Day
-1.3%
1y
-95.2%
5y
-99.8%
52w
-95.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1839d
EMA 21
0.16
EMA 50
0.24
EMA 200
0.94
20d high
-17.4%
5y high
-99.9%
5y range
0th
Positions held
Your positionsVVOS isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-12
Hold
avoid
Signal
Sell
Target
$0.17
Stop
$0.13
Stop distance
12.7%
Target vs last
+14.2%
Fundamentals
| Market cap | $5.02M | Enterprise value | $14.67M | Trailing P/E | — | Forward P/E | -0.18 |
| PEG | — | Price / book | -0.44 | Beta | 6.07 | Dividend yield | 0.00% |
| Revenue growth | 34.9% | Earnings growth | — | Gross margin | 61.9% | Operating margin | -93.6% |
| Profit margin | -121.8% | ROE | -85.9% | ROA | -56.2% | Debt / equity | — |
| Current ratio | 0.21 | Free cash flow | -$8.53M | Analyst recommendation | none | Mean target | $2.12 |
| 52w high | $3.28 | 52w low | $0.13 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $5.2M | $5.1M | $3.8M | $6.8M | $3.8M | — |
| Op margin | -93.6% | -128.7% | -166.9% | -69.8% | -127.4% | — |
| Net income | -$5.5M | -$7.7M | -$7.0M | -$5.4M | -$5.0M | — |
| Gross margin | 57.3% | 59.5% | 78.1% | 58.0% | 55.2% | — |
| Gross profit | $3.0M | $3.1M | $3.0M | $3.9M | $2.1M | — |
| Operating income | -$4.8M | -$6.6M | -$6.4M | -$4.7M | -$4.9M | — |
- Revenue +0% vs prior quarter ($5.2M vs $5.1M).
- Gross margin 57.3% (was 59.5% prior quarter).
- Operating margin expanded to -93.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $17.4M | $15.0M | $13.8M | $16.0M | — |
| Op margin | -114.1% | -74.3% | -125.3% | -156.2% | — |
| Net income | -$21.2M | -$11.1M | -$13.6M | -$23.8M | — |
| Gross margin | 60.4% | 60.0% | 59.9% | 62.5% | — |
| Gross profit | $10.5M | $9.0M | $8.3M | $10.0M | — |
| Operating income | -$19.9M | -$11.2M | -$17.3M | -$25.0M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsVVOS · daily-4.5% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin